Comparison of oncolytic virotherapy and nanotherapy as two new miRNA delivery approaches in lung cancer

Comparison of oncolytic virotherapy and nanotherapy as two new miRNA delivery approaches in lung cancer

Lung cancer is known as the second leading cause of cancer death. Finding ways to detect early-stage lung cancer can remarkably increase the survival rate. Biomarkers such as microRNAs can be helpful in cancer diagnosis, predicting its prognosis, and patients' chances of survival. Numerous stud...

Full description

Bibliographic Details
Main Authors: Akbar Ghorbani Alvanegh, Shahla Mohammad Ganji, Ali kamel, Mahmood Tavallaie, Alireza Rafati, Ayyoob Arpanaei, Ruhollah Dorostkar, Hadi Esmaeili Gouvarchin Ghaleh
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Biomedicine & Pharmacotherapy
Subjects:
miRNAs profile
Oncolytic viruses
Nanoparticle
miRNA delivery
Lung cancer
Oncolytic virotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221005370

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221005370

Similar Items